| Company |
Market Cap |
Revenue Growth |
Profit Margin |
Cash |
PE |
| 3SBio Inc. |
$269.43M |
23.64% |
18.38% |
$108.47M |
22.36 |
| Aastrom Biosciences, Inc. |
$36.54M |
-33.33% |
-22850% |
$14.73M |
|
| Abraxis BioScience, Inc. |
$1.60B |
13.62% |
-18.19% |
|
|
| ACADIA Pharmaceuticals, Inc. |
$62.76M |
453.12% |
-490.96% |
$47.05M |
|
| Achillion Pharmaceuticals, Inc. |
$76.51M |
-104.69% |
-11216.67% |
$9.71M |
|
| Acorda Therapeutics, Inc. |
$1.38B |
15.89% |
-155.61% |
$272.38M |
|
| Adeona Pharmaceuticals, Inc. |
$23.82M |
|
-1260% |
$3.53M |
|
| Advanced Life Sciences Holdings, Inc. |
|
404.76% |
-136.79% |
$2.84M |
|
| Adventrx Pharmaceuticals Inc. |
$29.97M |
|
|
$3.15M |
|
| Aeterna Zentaris Inc. |
$47.39M |
-22.39% |
-131.89% |
$43.61M |
|
| Affymax, Inc. |
$482.35M |
29.97% |
-43.45% |
$160.59M |
|
| Alfacell Corp. |
$11.35M |
|
|
$1.95M |
|
| Alnylam Pharmaceuticals, Inc. |
$757.82M |
-5.75% |
-37.98% |
$217.96M |
|
| Alseres Pharmaceuticals, Inc. |
$20.81M |
|
|
$1.33M |
|
| Altus Pharmaceuticals Inc. |
$2.80M |
|
|
$11.75M |
|
| American Oriental Bioengineering Inc. |
$323.38M |
11.66% |
12.73% |
$115.92M |
8.43 |
| Amgen Inc. |
$58.12B |
1.55% |
24.44% |
$13.44B |
12.73 |
| Amicus Therapeutics, Inc. |
$75.20M |
1040.09% |
66.61% |
$78.21M |
|
| Amylin Pharmaceuticals Inc. |
$3.24B |
-8.38% |
-27.10% |
$667.76M |
|
| Anadys Pharmaceuticals Inc. |
$83.20M |
|
|
$20.48M |
|
| Anesiva, Inc. |
$4.05M |
|
|
$1.24M |
|
| Anika Therapeutics Inc. |
$73.79M |
17.28% |
13.99% |
$38.54M |
17.92 |
| Antigenics Inc. |
$68.68M |
30.43% |
-1178.89% |
$34M |
|
| ARCA biopharma, Inc. |
$21.78M |
-100% |
|
$10.64M |
|
| Ariad Pharmaceuticals Inc. |
$378.66M |
39.61% |
-967.91% |
$57.47M |
|
| Athersys, Inc. |
$54.90M |
234.62% |
-575.86% |
$21.29M |
|
| BioCryst Pharmaceuticals Inc. |
$317.33M |
60.34% |
27.60% |
$69.57M |
|
| BioDelivery Sciences International Inc. |
$85.68M |
-100% |
|
$25.87M |
|
| Biogen Idec Inc. |
$17.27B |
5.44% |
27.12% |
$1.26B |
17.88 |
| Bioheart, Inc. |
$12.59M |
|
-26500% |
$0.05M |
|
| BioMarin Pharmaceutical Inc. |
$2.31B |
-12.29% |
5.41% |
$300.67M |
|
| Bionovo Inc. |
$36.65M |
|
-2331.25% |
$2.25M |
|
| Biopure Corp. |
|
-62.22% |
-526.47% |
$0.24M |
|
| BioSante Pharmaceuticals, Inc. |
$61.45M |
-87.50% |
-63700% |
$13.16M |
|
| BioSpecifics Technologies Corp. |
$176.32M |
135.29% |
-50% |
$9.28M |
50.88 |
| Cadence Pharmaceuticals Inc. |
$457.40M |
|
|
$98.24M |
|
| Cambrex Corp. |
$124.15M |
-9.93% |
-4.79% |
$52.36M |
11.78 |
| Cardiovascular Systems Inc. |
$80.80M |
|
-44.90% |
$46.14M |
10.38 |
| Cardium Therapeutics Inc. |
$23.66M |
-58.62% |
|
$4.41M |
|
| CEL-SCI Corp. |
$112.46M |
|
|
$36.04M |
|
| Celgene Corporation |
$28.87B |
21.13% |
33.40% |
|
37.84 |
| Cell Genesys, Inc. |
$31.62M |
-100% |
|
$35.54M |
|
| Cell Therapeutics, Inc. |
$622.22M |
-99.22% |
-136900% |
$37.81M |
|
| Cerus Corporation |
$110.30M |
50.69% |
-89.40% |
$19.92M |
|
| Charles River Laboratories International Inc. |
$2.52B |
-5.16% |
5.95% |
$182.57M |
21.97 |
| Chelsea Therapeutics International Ltd. |
$125.73M |
|
|
$41.52M |
|
| Clinical Data, Inc. |
$497.33M |
-65.57% |
-613.82% |
$37.21M |
|
| CombiMatrix Corporation |
$42.88M |
-3.96% |
-340.21% |
$7.90M |
|
| CombinatoRx, Incorporated |
$43.83M |
-21.26% |
-301.46% |
$19.67M |
|
| Compugen Ltd. |
$146.09M |
-100% |
|
$9.69M |
|
| Corcept Therapeutics Inc. |
$134.42M |
|
-27250% |
$20.64M |
|
| Cornerstone Therapeutics Inc. |
$135.09M |
48.31% |
8.74% |
$18.85M |
7.91 |
| Crucell NV |
$1.74B |
23.07% |
14.02% |
$457.20M |
48.73 |
| CuraGen Corp. |
$82.38M |
-100% |
|
$76.03M |
|
| Curis Inc. |
$211.69M |
-44.69% |
-157.56% |
$25.24M |
|
| Cyclacel Pharmaceuticals, Inc. |
$60.59M |
-14.81% |
-1356.52% |
$14.43M |
|
| Cypress Bioscience, Inc. |
$189.92M |
519.39% |
-90.12% |
$144.80M |
|
| Cytokinetics Inc. |
$201.07M |
-67.62% |
-1228.43% |
$114.72M |
7.86 |
| Cytori Therapeutics, Inc. |
$188.84M |
-40.09% |
-489.21% |
$13.14M |
|
| CytRx Corporation |
$133.58M |
655.43% |
55.54% |
$35.51M |
|
| DARA BioSciences, Inc |
$13.38M |
|
|
$5.87M |
|
| Dendreon Corp. |
$4.22B |
0% |
-151833.33% |
$248.41M |
|
| Discovery Laboratories Inc. |
$62.29M |
-100% |
|
$17.68M |
|
| Dyax Corp. |
$292.05M |
-17.85% |
-270.29% |
$41.10M |
|
| Emergent BioSolutions, Inc. |
$508.82M |
50.49% |
7.86% |
$103.13M |
16.69 |
| EntreMed Inc. |
$69.15M |
4.86% |
2.45% |
$10.02M |
|
| Enzon Pharmaceuticals Inc. |
$456.01M |
-8.72% |
-0.41% |
|
1002 |
| EPIX Pharmaceuticals, Inc. |
$21.81M |
51.45% |
-266.85% |
$14.73M |
|
| Eurand N.V. |
$510.68M |
9.44% |
-1.30% |
$44.75M |
|
| EXACT Sciences Corp. |
$156.28M |
-1227.27% |
-146.77% |
$24.32M |
|
| Exelixis, Inc. |
$677.63M |
49.07% |
-65.40% |
$203.08M |
|
| Facet Biotech Corporation |
$676.39M |
127.07% |
-203.51% |
$300.83M |
|
| Forbes Medi Tech Inc. |
$1.54M |
-37.04% |
-107.56% |
$1.08M |
|
| GenVec Inc. |
$295.29M |
-30.24% |
-121.50% |
$14.22M |
|
| Genzyme Corp. |
$15.21B |
-7.92% |
2.15% |
$905.87M |
36.99 |
| Gilead Sciences Inc. |
$42.72B |
42.30% |
39.47% |
$1.66B |
16.77 |
| GTC Biotherapeutics, Inc. |
$8.60M |
-74.40% |
-654.67% |
$1.75M |
|
| GTX Inc. |
$124.92M |
18.03% |
-356.11% |
$55.53M |
|
| Halozyme Therapeutics, Inc. |
$666.62M |
23.17% |
-459.08% |
$77.63M |
|
| Hana Biosciences, Inc. |
$14.93M |
|
|
$8.31M |
|
| Hemispherx Biopharma, Inc. |
$92.16M |
100% |
-12150% |
$61.04M |
|
| Heska Corp. |
$48.99M |
12.51% |
2.65% |
$5.40M |
31.33 |
| Hollis-Eden Pharmaceuticals, Inc. |
$17.00M |
|
|
$12.13M |
|
| Human Genome Sciences Inc. |
$5.72B |
310.22% |
-18.39% |
$719.18M |
|
| Idenix Pharmaceuticals Inc. |
$189.07M |
-28.57% |
-403.61% |
$46.93M |
|
| Idera Pharmaceuticals, Inc. |
$116.18M |
63.14% |
38.61% |
$31.74M |
15.47 |
| IGI, Laboratories, Inc. |
$11.33M |
-18.56% |
-115.19% |
$2.48M |
|
| Illumina Inc. |
$5.02B |
12.20% |
6.48% |
$693.52M |
75.75 |
| Immunogen Inc. |
$421.67M |
-66.67% |
-418.33% |
$53M |
|
| Incyte Corporation |
$1.54B |
630.85% |
-1287.34% |
$489.44M |
|
| Inhibitex Inc. |
$60.10M |
-63.29% |
-1541.38% |
$21.07M |
|
| Insmed Incorporated |
$150.14M |
-39.31% |
-6.07% |
$121.97M |
1.26 |
| InterMune Inc. |
$1.74B |
17.11% |
-32.11% |
$126.52M |
|
| Jazz Pharmaceuticals, Inc. |
$350.19M |
95.41% |
14.76% |
$18.58M |
|
| La Jolla Pharmaceutical Co. |
$6.57M |
|
|
$5.83M |
|
| Lexicon Pharmaceuticals, Inc. |
$224.91M |
-77.80% |
-1560.28% |
$162.50M |
|
| Life Technologies Corporation |
$9.53B |
61.13% |
5.62% |
|
67.62 |
| Ligand Pharmaceuticals Inc. |
$215.87M |
12.75% |
21.69% |
$53.23M |
191 |
| MannKind Corp. |
$842.87M |
|
|
$56.55M |
|
| Martek Biosciences Corp. |
$783.18M |
2.75% |
10.74% |
$157.34M |
19.30 |
| MDRNA, Inc. |
$43.20M |
-85.37% |
-11683.33% |
$4.58M |
|
| Medarex, Inc. |
$2.06B |
95.78% |
-150% |
$340.64M |
|
| MediciNova Inc. |
$99.24M |
|
|
$47.03M |
|
| Medicis Pharmaceutical Corp. |
$1.55B |
31.68% |
21.72% |
$528.27M |
21.88 |
| Medivation, Inc. |
$422.06M |
|
-85.50% |
$214.45M |
|
| Metabasis Therapeutics Inc. |
$10.90M |
248.57% |
54.51% |
$2.21M |
|
| Micromet, Inc. |
$523.63M |
-11.13% |
-507.78% |
$117.59M |
|
| Molecular Insight Pharmaceuticals, Inc. |
$42.15M |
66.67% |
-21380% |
$71.81M |
|
| Momenta Pharmaceuticals Inc. |
$641.82M |
2.56% |
-365.34% |
$107.28M |
|
| Nabi Biopharmaceuticals |
$298.98M |
|
10.58% |
$118.99M |
|
| Nanogen, Inc. |
$13.17M |
-3.15% |
-20.96% |
|
|
| NeoPharm, Inc. |
$1.71M |
|
|
$5.36M |
|
| Neose Technologies Inc. |
$21.24M |
-23.95% |
-220% |
$7.09M |
|
| Neuralstem Inc. |
$72.56M |
|
|
$2.42M |
|
| Neurobiological Technologies Inc. |
$3.50M |
68.91% |
89.72% |
$26.48M |
0.31 |
| Neurocrine Biosciences Inc. |
$96.46M |
1.37% |
-1070.27% |
$53.45M |
|
| Nile Therapeutics, Inc |
$31.66M |
|
|
$3.17M |
|
| Novavax, Inc. |
$215.62M |
5.26% |
-3765% |
$34.37M |
|
| NPS Pharmaceuticals, Inc. |
$192.27M |
-8.39% |
-8.98% |
$116.74M |
|
| Nutrition 21 Inc. |
|
-83.99% |
-105.83% |
$0.26M |
|
| Obagi Medical Products, Inc. |
$259.20M |
-4.27% |
12.25% |
$31.19M |
29.57 |
| ONCOLYTICS BIOTECH |
$144.74M |
|
|
$9.28M |
|
| Oncothyreon Inc |
$113.58M |
-97.39% |
-21100% |
$22.70M |
10.80 |
| Onyx Pharmaceuticals Inc. |
$2.02B |
37.60% |
-8.06% |
$577.70M |
115.93 |
| Opexa Therapeutics, Inc. |
$30.32M |
|
|
$8.18M |
|
| Optimer Pharmaceuticals, Inc. |
$445.93M |
61.54% |
-4495.24% |
$38.18M |
|
| Orthologic Corp. |
$40.37M |
|
|
$38.68M |
|
| OSI Pharmaceuticals Inc. |
$3.36B |
17.85% |
15.76% |
$542.06M |
9.16 |
| Osiris Therapeutics, Inc. |
$251.60M |
958% |
-58.51% |
$102.89M |
|
| Oxigene Inc. |
$76.19M |
-100% |
|
$22.02M |
|
| Panacos Pharmaceuticals Inc. |
$1.07M |
-33.33% |
-40750% |
$26.88M |
|
| PDL BioPharma, Inc. |
$788.63M |
-15.16% |
49.03% |
$303.22M |
5.78 |
| Peregrine Pharmaceuticals Inc. |
$156.96M |
255.67% |
-40.43% |
$13.59M |
|
| Pharmos Corp. |
|
|
|
$4.62M |
|
| Pluristem Therapeutics, Inc. |
$7.74M |
|
|
$3.33M |
|
| Polydex Pharmaceuticals Ltd. |
|
-16.06% |
-19.13% |
$0.49M |
|
| Poniard Pharmaceuticals, Inc. |
$54.26M |
|
|
$40.39M |
|
| Progenics Pharmaceuticals Inc. |
$168.36M |
-69.03% |
-240.04% |
$102.95M |
|
| Protalix BioTherapeutics, Inc. |
$537.03M |
|
|
$81.26M |
|
| Qiagen NV |
$5.27B |
21.88% |
15.38% |
$865.55M |
36.21 |
| QLT Inc. |
$270.96M |
-72.29% |
|
$188.11M |
2.71 |
| Questcor Pharmaceuticals, Inc. |
$462.67M |
-4.11% |
32.50% |
$75.69M |
18.02 |
| Regeneron Pharmaceuticals Inc. |
$1.99B |
79.11% |
-0.86% |
$379.79M |
|
| Repligen Corporation |
$115.04M |
-6.64% |
-6.23% |
$48.56M |
|
| Repros Therapeutics Inc. |
$12.34M |
-100% |
|
$2.54M |
|
| Rexahn Pharmaceuticals, Inc. |
$75.90M |
100% |
-6200% |
$4.14M |
|
| Sangamo Biosciences Inc. |
$268.11M |
49.93% |
-23.34% |
$84.93M |
|
| Savient Pharmaceuticals, Inc. |
$1.01B |
-21.82% |
-25.58% |
$108.17M |
|
| Seattle Genetics Inc. |
$1.19B |
44.18% |
-170.21% |
$266.47M |
|
| Senesco Technologies Inc. |
$9.13M |
|
-1214.29% |
$0.75M |
|
| Sequenom Inc. |
$371.85M |
-20.31% |
-161.39% |
$51.49M |
|
| Sinovac Biotech Ltd. |
$285.91M |
142.63% |
24.59% |
$46.58M |
21.06 |
| StemCells Inc. |
$143.20M |
82.35% |
-1687.10% |
$38.80M |
|
| Sunesis Pharmaceuticals Inc. |
$27.88M |
-98.04% |
-49500% |
$3.87M |
|
| Targacept, Inc. |
$528.79M |
-47.39% |
-769.97% |
$111.05M |
|
| Targeted Genetics Corp. |
$3.72M |
113.22% |
18.06% |
$3.97M |
|
| Techne Corp. |
$2.45B |
5.88% |
37.73% |
$249.47M |
23.52 |
| Theravance Inc. |
$798.95M |
-35.80% |
-581.41% |
$155.38M |
|
| Threshold Pharmaceuticals Inc. |
$62.76M |
-100% |
|
$37.31M |
|
| Tongjitang Chinese Medicines Co. |
$123.52M |
-5.78% |
-13.12% |
$53.74M |
|
| Transcept Pharmaceuticals, Inc. |
$103.31M |
2211.11% |
-183.17% |
$93.19M |
|
| Transition Therapeutics Inc. |
$61.07M |
|
-609.57% |
$33.85M |
|
| Trimeris Inc. |
$55.20M |
-27.59% |
41.94% |
$35.61M |
8.23 |
| Trubion Pharmaceuticals Inc. |
$65.74M |
18.04% |
-140% |
$61.73M |
|
| Vanda Pharmaceuticals, Inc. |
$330.21M |
|
|
$20.67M |
|
| VIA Pharmaceuticals, Inc. |
$4.13M |
|
|
$2.91M |
|
| Vical Inc. |
$203.10M |
-2.66% |
-285.55% |
$65.46M |
|
| Vion Pharmaceuticals Inc. |
|
-80% |
-69100% |
$37.99M |
|
| ViroPharma Inc. |
$1.04B |
75.59% |
13.67% |
$331.67M |
|
| Xenoport, Inc. |
$277.91M |
-45.71% |
-318.58% |
$143.66M |
|
| XOMA Ltd. |
$123.17M |
-41.50% |
13.80% |
$23.90M |
|
| ZIOPHARM Oncology, Inc. |
$81.93M |
|
|
$7.08M |
|
| ZymoGenetics, Inc. |
$406.67M |
72.40% |
21.85% |
$174.12M |
|
